IL9 and COVID-19: Intriguingly, levels of IL-9, eotaxin, MIP-1β, and RANTES in patients who recovered from COVID-19 were found to be the lowest among the 3 groups (Figure 2A), further indicating that cytokine levels are dysregulated in patients with COVID-19 after clinical symptom remission.